Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
RTI-336 as a Treatment for Methamphetamine Dependence (NCT01601717)Baylor College of Medicine2010-01-01
A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects (NCT01221259)Eisai Inc.2010-01-01
Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease (NCT01046773)University of California, Los Angeles2010-01-01
A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malaria (NCT00984763)University of Oxford2010-01-01
TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278 (NCT01031589)Tibotec Pharmaceuticals, Ireland2010-01-01
Measure the Effects of Specific Thoracic Chiropractic Adjustments on Blood Pressure and Pulse Rate (NCT01591967)Spinal Missions, Inc., LLC2010-01-01
Autologous Vaccine for Follicular Lymphoma (NCT01022255)Icon Genetics GmbH2010-01-01
Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice (NCT01108315)BrightOutcome2010-01-01
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease (NCT01016418)Hadassah Medical Organization2010-01-01
Does an Integrative Neuro-psychotherapy Program Foster the Adjustment in Depressed Stroke Patients? A Randomized Controlled Study. (NCT01039857)University of Bern2010-01-01
Bioequivalence Study Comparing Two Formulations of Escitalopram (NCT01395433)H. Lundbeck A/S2010-01-01
Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) (NCT01039194)Bristol-Myers Squibb2010-01-01
Nutritional Education for Dependant Patients (NCT01360775)Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina2010-01-01
Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs (NCT01033552)Masonic Cancer Center, University of Minnesota2010-01-01
Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers (NCT02221401)Boehringer Ingelheim2010-01-01
Effects Of Passive Smoking On The Respiratory System Mechanics Of Healthy Non-Smokers In Different Body Positions (NCT02171871)Hellenic Anticancer Society2010-01-01
Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles (NCT01007240)Hadassah Medical Organization2010-01-01
Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy Volunteers (NCT01047605)Pascoe Pharmazeutische Praeparate GmbH2010-01-01
Stem Cell Implantation in Patients Undergoing CABG (NCT01721902)Miltenyi Biotec, Inc.2010-01-01
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour (NCT01058616)Lytix Biopharma AS2010-01-01
Study Evaluating MOA-728 Administered in Healthy Men (NCT00427258)Bausch Health Americas, Inc.2010-01-01
Docetaxel and Sirolimus in Patients With Advanced Malignancies (NCT01054313)M.D. Anderson Cancer Center2010-01-01
Effect of Quercetin in Prevention and Treatment of Oral Mucositis (NCT01732393)Mashhad University of Medical Sciences2010-01-01
Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers (NCT01199965)Allergan2010-01-01
Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01716364)Peter MacCallum Cancer Centre, Australia2010-01-01
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors (NCT01165905)Traws Pharma, Inc.2010-01-01
Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia (NCT01279096)University Hospital, Lille2010-01-01
The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin (NCT01043510)Novo Nordisk A/S2010-01-01
Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma (NCT01045928)Case Comprehensive Cancer Center2010-01-01
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers (NCT02259972)Boehringer Ingelheim2010-01-01
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets (NCT01055691)AstraZeneca2010-01-01
Effect on Shoulder Training Using Rehabilitation Robot for Stroke Patients (NCT01117194)National Taiwan University Hospital2010-01-01
Warming Contrast Media for Hysterosalpingography (NCT01339338)Taizhou Hospital2010-01-01
Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) (NCT01116635)University of British Columbia2010-01-01
A Dose-escalation Study in Subjects With Advanced Malignancies (NCT01072266)Incyte Corporation2010-01-01
A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers (NCT01034748)Pfizer2010-01-01
A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia (NCT01055561)Chengdu University of Traditional Chinese Medicine2010-01-01
A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine (NCT01053767)Novartis Vaccines2010-01-01
Evaluation of Web-Based Recovery Monitoring With Clinical Alerts (NCT01465555)Treatment Research Institute2010-01-01
Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy Volunteers (NCT02182375)Boehringer Ingelheim2010-01-01
Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male (NCT01014416)Korea Otsuka Pharmaceutical Co., Ltd.2010-01-01
Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers (NCT01082484)University Hospital, Grenoble2010-01-01
An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function (NCT01278849)Novartis Pharmaceuticals2010-01-01
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma (NCT01684449)Grupo Espanol de Investigacion en Sarcomas2010-01-01
Auriculotherapy as a Coping Strategy in Professional Nursing (NCT01424072)University of Sao Paulo2010-01-01
Manual Therapy on Head-repositioning Accuracy and Static Postural Balance in Neck Pain Patients (NCT01310595)The Hong Kong Polytechnic University2010-01-01
Sleep Apnea Treatment With Expiratory Resistance(Provent™) (NCT01061476)Johns Hopkins University2010-01-01
Phase 1 Study to Determine Safety, Blood PK and Lung Penetration (NCT01034774)Achaogen, Inc.2010-01-01
Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan (NCT01018745)Bristol-Myers Squibb2010-01-01
Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma (NCT01035658)SCRI Development Innovations, LLC2010-01-01
Pilot Study of Sodium Nitrite in Resuscitated Cardiac Arrest Patients (NCT01178359)University of Washington2010-01-01
HAI Abraxane With Gemcitabine and Bevacizumab (NCT01057264)M.D. Anderson Cancer Center2010-01-01
Sympathetic Neural Outflow During Xenon Anesthesia in Humans (NCT01043419)Air Liquide Santé International2010-01-01
Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine (NCT01192828)University of Colorado, Denver2010-01-01
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma (NCT01051934)National Cancer Institute (NCI)2009-12-29
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer (NCT01042535)H. Lee Moffitt Cancer Center and Research Institute2009-12-28
A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761 (NCT01031472)ViiV Healthcare2009-12-21
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants (NCT05984251)Amgen2009-12-21
A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers (NCT01371799)GlaxoSmithKline2009-12-17
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas (NCT01024907)Abramson Cancer Center at Penn Medicine2009-12-17
A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects (NCT01037582)Novo Nordisk A/S2009-12-17
Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT01059552)Fox Chase Cancer Center2009-12-16
MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00869752)NCIC Clinical Trials Group2009-12-16
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma (NCT01668134)Washington University School of Medicine2009-12-16
Haploidentical PBMC Transplant for Severe Congenital Anemias (NCT00977691)National Heart, Lung, and Blood Institute (NHLBI)2009-12-14
A Multiple Dose Study Of Ertugliflozin (PF-04971729, MK-8835) In Otherwise Healthy Overweight And Obese Volunteers (MK-8835-037) (NCT01018823)Merck Sharp & Dohme LLC2009-12-14
Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma (NCT01024231)Bristol-Myers Squibb2009-12-14
A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients (NCT01183494)University of Chicago2009-12-12
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies (NCT01004224)Novartis Pharmaceuticals2009-12-11
To Investigate the Clinical Efficacy of an Experimental Toothpaste (NCT01079910)GlaxoSmithKline2009-12-09
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy (NCT01051063)GlaxoSmithKline2009-12-09
Effect of SRT2104 on Endotoxin-induced Inflammation (NCT01014117)GlaxoSmithKline2009-12-09
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin (NCT01330303)GlaxoSmithKline2009-12-08
Safety and Tolerability of Odanacatib (0822-059) (NCT01068262)Merck Sharp & Dohme LLC2009-12-08
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer (NCT01394016)Eli Lilly and Company2009-12-07
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers (NCT01018628)GlaxoSmithKline2009-12-07
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). (NCT00946647)Novartis Pharmaceuticals2009-12-02
Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents (NCT01033383)Yale University2009-12-01
Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers (NCT00992069)National Institute of Allergy and Infectious Diseases (NIAID)2009-12-01
Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer (NCT00889187)Dana-Farber Cancer Institute2009-12-01
Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis (NCT01027728)Amgen2009-12-01
Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene (NCT01289756)Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)2009-12-01
Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer (NCT01064375)Maria Liljefors2009-12-01
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer (NCT02131506)Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2009-12-01
A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition (NCT01044342)AstraZeneca2009-12-01
Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® (NCT01540734)GlaxoSmithKline2009-12-01
Radioactive Holmium Microspheres for the Treatment of Liver Metastases (NCT01031784)UMC Utrecht2009-12-01
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects (NCT01010542)Pfizer2009-12-01
Safety and Pharmacokinetics of SNX-001 in Healthy Aged Volunteers (NCT01269476)SeneXta Therapeutics SA2009-12-01
Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients. (NCT01025648)Amphastar Pharmaceuticals, Inc.2009-12-01
A Study to Compare Two Paracetamol Formulations. (NCT01592227)GlaxoSmithKline2009-12-01
Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers (NCT01027182)Changi General Hospital2009-12-01
Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival (NCT01072357)Reza Dana, MD2009-12-01
First-in-Human Single Ascending and Multiple Dose of GLPG0555 (NCT01023321)Lakefront Biotherapeutics NV2009-12-01
Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer (NCT01061840)Gradalis, Inc.2009-12-01
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme (NCT01122888)National Cancer Institute (NCI)2009-12-01
Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics (NCT01845194)Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH2009-12-01
Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001) (NCT01025843)Merck Sharp & Dohme LLC2009-12-01
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas (NCT01040559)Centre Hospitalier Universitaire Dijon2009-12-01
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 (NCT00622401)Beth Israel Deaconess Medical Center2009-12-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.